Cargando…
Immunotherapy and Radioimmunotherapy for Desmoplastic Small Round Cell Tumor
Desmoplastic small round cell tumor (DRSCT) is a highly aggressive primitive sarcoma that primarily affects adolescent and young adult males. The 5-year survival rate is 15-30% and few curative treatment options exist. Although there is no standard treatment for DSRCT, patients are most often treate...
Autores principales: | Espinosa-Cotton, Madelyn, Cheung, Nai-Kong V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641660/ https://www.ncbi.nlm.nih.gov/pubmed/34869013 http://dx.doi.org/10.3389/fonc.2021.772862 |
Ejemplares similares
-
Identification of immunotherapy and radioimmunotherapy targets on desmoplastic small round cell tumors
por: Espinosa-Cotton, Madelyn, et al.
Publicado: (2023) -
Genomic Breakpoint Characterization and Transcriptome Analysis of Metastatic, Recurrent Desmoplastic Small Round Cell Tumor
por: Magrath, Justin W., et al.
Publicado: (2023) -
Desmoplastic small round cell tumor cancer stem cell-like cells resist chemotherapy but remain dependent on the EWSR1-WT1 oncoprotein
por: Magrath, Justin W., et al.
Publicado: (2022) -
Mini-Review on Targeted Treatment of Desmoplastic Small Round Cell Tumor
por: Bexelius, Tomas S., et al.
Publicado: (2020) -
Giant desmoplastic small round cell tumor of the abdomen: A case report
por: Wang, Wuke, et al.
Publicado: (2022)